However, TL1A/DR3 signaling is considered to play a pathogenic role in IBD through various mechanisms, which brings forward a high risk for the exacerbation of intestinal inflammation by activation of DR3 signaling12. Here, TNFSF15 is linked to inflammatory bowel disease.